Regulus Therapeutics RGLS
173.54
2.86
1.68
%
已收盤:06/26 20:00 (臺灣)
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
---|---|---|---|---|---|---|
2025Q1 | 1.75 | 69 | -13.25 | -10 | -12.12 | 75 |
2024Q4 | 1.58 | 76 | -15.67 | -13 | -14.38 | 84 |
2024Q3 | 1.57 | 87 | -15.20 | -14 | -14.21 | 94 |
2024Q2 | 1.79 | 98 | -10.73 | -11 | -10.11 | 104 |
2024Q1 | 2.88 | 108 | -13.15 | -8 | -11.69 | 114 |
2023Q4 | 1.28 | 21 | -32.61 | -8 | -23.54 | 31 |
2023Q3 | 1.37 | 28 | -25.13 | -8 | -19.23 | 38 |
2023Q2 | 1.47 | 34 | -23.15 | -7 | -17.39 | 44 |
2023Q1 | 0.85 | 27 | -23.84 | -7 | -17.05 | 37 |
2022Q4 | 1.37 | 33 | -18.63 | -7 | -13.75 | 47 |
2022Q3 | 1.70 | 40 | -18.41 | -8 | -14.19 | 52 |
2022Q2 | 2.07 | 42 | -15.85 | -7 | -12.59 | 54 |
2022Q1 | 2.98 | 49 | -12.90 | -7 | -10.38 | 61 |
2021Q4 | 3.15 | 55 | -16.99 | -7 | -12.80 | 68 |
2021Q3 | 6.91 | 29 | -26.21 | -9 | -18.64 | 43 |
2021Q2 | 8.13 | 37 | -18.87 | -6 | -13.51 | 50 |
2021Q1 | 15.60 | 27 | -22.63 | -6 | -15.53 | 40 |
2020Q4 | 13.50 | 26 | -7.83 | -1 | -4.07 | 38 |
2020Q3 | 5.14 | 8 | -18.66 | -2 | -5.34 | 27 |
2020Q2 | 6.82 | 9 | -59.16 | -7 | -21.45 | 30 |